Diseases & Conditions Related News
Reducing cardiovascular and cerebrovascular deaths with AstraZeneca
AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as...
Arteriograph: using pulse wave analysis in the COVID-19 pandemic
Patients with hypertension are at a higher risk of contracting the SARS-CoV-2 viral infection that causes COVID-19.
The World Health Organization (WHO) has identified hypertension...
First global resolution on meningitis prevention and control
A global roadmap to defeat meningitis by 2030 has been established under the leadership of the World Health Organization.
At the 73rd Session of the...
UK forms new strategy to improve rare disease diagnosis and treatment
The UK has created a new framework to accelerate the diagnosis of rare diseases, as well as improving treatment and raising awareness.
More than 3.5...
Five-minute screening for lung inflammation
Inflammacheck offers rapid point-of-care testing of the lungs, supporting healthcare professionals to rapidly identify active lung inflammation
Drop in number of people seeking mental health support during lockdown
New research has shown a drop of more than third in the number of people seeking help for mental illness or self-harm during the...
Study shows different immune response in cancer patients to COVID-19
Cancer patients have shown different responses to the COVID-19 virus depending on the type of cancer they have.
In a study, carried out by Cancer...
Artificial enzyme could lead to new Parkinson’s disease treatment
A team of researchers have created an artificial enzyme that could help form a new treatment for the neurodegenerative Parkinson’s disease.
The team from Johns...
Treating depression by ‘erasing’ neuroplasticity damage caused by stress
Researchers have used epigenetic modulators in an attempt at ‘erasing’ damage to neuroplasticity caused by stress, showing that acute intervention in epigenetic mechanisms produces...
Potential treatment kills lymphoma whilst leaving healthy cells alone
Scientists have demonstrated a potential new strategy for treating lymphomas – a group of cancers that start in infection-fighting cells called lymphocytes.
The team of...
Cardiac surgery survival inequalities between private and NHS patients
A new study has revealed that private medical patients are 20% less likely to die or develop complications following surgery than NHS patients.
The study,...
Calls for urgent reforms to improve care for rare disease patients
Organisations are calling on the UK Government and the NHS to implement urgent reforms in order to improve care for patients in the UK...
Renewed collaboration to eliminate tropical diseases
A decades-long collaboration between the World Health Organization (WHO) and Sanofi has been renewed in order to sustain efforts to eliminate neglected tropical diseases.
The...
New variant of COVID-19 being investigated by PHE
A new variant of the virus that causes COVID-19 has been discovered in the South East of England which Public Health England (PHE) is...
New study shows Lyme disease alters immune system
A new study has shown that the bacteria that causes Lyme disease alters the immune system, causing it to attack the healthy cells in...
Predicting Alzheimer’s disease risk by testing memory
Testing people’s memory over four weeks could help to identify who is at higher risk of developing Alzheimer’s disease.
New research, led by a team...
Leading causes of death worldwide revealed by WHO
The World Health Organization has revealed that noncommunicable diseases now make up seven of the world’s top 10 causes of death worldwide.
The WHO’s 2019...
Research shows one in five people with multiple sclerosis now under 30
New research from the MS Society has revealed that one in five people diagnosed with Multiple Sclerosis are now under the age of 30.
The...
Increased risk of dying for rare autoimmune patients during COVID-19
A new study has shown that people living with rare autoimmune diseases are at heightened risk of dying during COVID-19, a finding that can...
Improving access to gene and cell therapies for people with rare diseases
A new report has addressed challenges to accessing gene and cell therapies for people living with rare diseases.
EURORDIS-Rare Diseases Europe and the partners of the...